Solid Biosciences (SLDB) FCF Margin: 2022-2024
Historic FCF Margin for Solid Biosciences (SLDB) over the last 2 years, with Dec 2024 value amounting to 39,798.67%.
- Solid Biosciences' FCF Margin rose 1909273.00% to 39,798.67% in Q4 2024 from the same period last year, while for Dec 2024 it was 29,607.65%, marking a year-over-year increase of 780924.00%. This contributed to the annual value of 29,607.65% for FY2024, which is 785878.00% up from last year.
- According to the latest figures from Q4 2024, Solid Biosciences' FCF Margin is 39,798.67%, which was up 37.57% from 28,930.49% recorded in Q3 2024.
- Solid Biosciences' FCF Margin's 5-year high stood at 39,798.67% during Q4 2024, with a 5-year trough of -879.69% in Q2 2022.
- Over the past 3 years, Solid Biosciences' median FCF Margin value was 24,719.32% (recorded in 2024), while the average stood at 22,886.16%.
- As far as peak fluctuations go, Solid Biosciences' FCF Margin surged by 2,610,581bps in 2023, and later crashed by 50,681bps in 2024.
- Over the past 3 years, Solid Biosciences' FCF Margin (Quarterly) stood at -879.69% in 2022, then skyrocketed by 2,610,581bps to 20,705.94% in 2023, then surged by 1,909,273bps to 39,798.67% in 2024.
- Its FCF Margin was 39,798.67% in Q4 2024, compared to 28,930.49% in Q3 2024 and 24,719.32% in Q2 2024.